| Literature DB >> 33800085 |
Marta C Coelho1,2, Tânia B Ribeiro1,3, Carla Oliveira1, Patricia Batista1, Pedro Castro1, Ana Rita Monforte1, António Sebastião Rodrigues4, José Teixeira2, Manuela Pintado1.
Abstract
In times of pandemic and when sustainability is in vogue, the use of byproducts, such as fiber-rich tomato byproducts, can be an asset. There are still no studies on the impact of extraction methodologies and the gastrointestinal tract action on bioactive properties. Thus, this study used a solid fraction obtained after the conventional method (SFCONV) and a solid fraction after the ohmic method (SFOH) to analyze the effect of the gastrointestinal tract on bioactive compounds (BC) and bioactivities. Results showed that the SFOH presents higher total fiber than SFCONV samples, 62.47 ± 1.24-59.06 ± 0.67 g/100 g DW, respectively. Both flours present high amounts of resistant protein, representing between 11 and 16% of insoluble dietary fiber. Furthermore, concerning the total and bound phenolic compounds, the related antioxidant activity measured by 2,2'-azino-bis-3-ethylbenzthiazoline-6-sulphonic acid (ABTS) radical cation decolorization assay presented significantly higher values for SFCONV than SFOH samples (p < 0.05). The main phenolic compounds identified in the two flours were gallic acid, rutin, and p-coumaric acid, and carotenoids were lycopene, phytofluene, and lutein, all known as health promoters. Despite the higher initial values of SFCONV polyphenols and carotenoids, these BCs' OH flours were more bioaccessible and presented more antioxidant capacity than SFCONV flours, throughout the simulated gastrointestinal tract. These results confirm the potential of ohmic heating to modify the bioaccessibility of tomato BC, enhancing their concentrations and improving their antioxidant capacity.Entities:
Keywords: Lycopersicum esculentum; bioaccessibility; bioavailability; byproducts; carotenoids; ohmic heating; phenolic compounds; tomato
Year: 2021 PMID: 33800085 PMCID: PMC8002034 DOI: 10.3390/foods10030554
Source DB: PubMed Journal: Foods ISSN: 2304-8158
Figure 1Gastrointestinal simulation and biological analysis throughout each step of digestion.
The proximate composition, total phenolic compounds, and total antioxidant activity of SFOH and SFCONV (g/100g DW).
| Chemical Composition | Sample (g/100 g) | |||
|---|---|---|---|---|
| SFOH | SFCONV | |||
| Proximate composition | Ash | 3.32 ± 0.21 a | 2.98 ± 0.16 a | |
| Protein | 18.72 ± 0.47 a | 16.29 ± 0.59 b | ||
| Total Fatty acids | 21.12 ± 0.51 a | 17.82 ± 0.3 b | ||
| Dietary Fiber | ||||
| TDF | 62.47 ±1.24 a | 59.06 ± 0.67 b | ||
| IDF | 50.99 ± 0.16 a | 46.01 ± 0.13 b | ||
| SDF | 10.86 ± 0.85 a | 12.98 ± 0.64 b | ||
| Phenolic composition | Free phenolic extract (FPC) | TPC | 1.46 ± 0.05 a | 0.80 ± 0.01 b |
| ABTS | 0.28 ± 0.01 b | 0.99 ± 0.15 a | ||
| ORAC | 2.44 ± 0.34 a | 1.60 ± 0.09 b | ||
| Bound phenolic extract (BPC) | TPC | 0.42 ± 0.03 b | 0.73 ± 0.12 a | |
| ABTS | 2.23 ± 0.21 a | 2.63 ± 0.11 a | ||
| ORAC | 2.41 ± 0.22 a | 2.71 ± 0.43 a | ||
Values are the mean of three replicates of three independent experiments ± standard deviation. TDF, total dietary fiber; IDF, insoluble dietary fiber; SDF, soluble dietary fiber; TPC, total phenolic compounds (g gallic acid eq./100 g DW); ABTS, antioxidant activity by ABTS method (g ascorbic acid eq./100 g DW); ORAC, antioxidant activity (g trolox eq./100 g DW). Different letters within the same row are statistically significantly different (determined by ANOVA, p < 0.05).
Constituents (g/100 g fiber DW) of SDF and IDF from SFOH and SFCONV samples.
| SFOH | SFCONV | |||
|---|---|---|---|---|
| SDF | IDF | SDF | IDF | |
| Klason Lignin | n.d. | 13.06 ± 0.52 b | n.d. | 14.09 ± 0.27 a |
| Glucose (as cellulose) | 24.42 ± 0.43 a | 55.32 ± 1.21 b | 32.1 ± 0.56 c | 50.23 ± 1.76 d |
| Hemicellulose | 15.12 ± 0.54 a | 25.2 ± 0.10 b | 12.71 ± 1.21 a | 24.72 ± 0.30 b |
| Xylose | * | 13.2 ± 0.10 a | * | 15.1 ± 0.17 b |
| Galactose | 1.87 ± 0.21 | * | * | 0.31 ± 0.021 |
| Mannose | * | * | 4.10 ± 0.12 a | * |
| Arabinose | 13.25 ± 0.86 | 12.81 ± 0.28 | 12.71 ± 1.21 | 9.31 ± 0.51 |
| Uronic acids** | 67.41 ± 2.15 a | 81.92 ± 1.98 b | 58.93 ± 2.56 c | 78.49 ± 2.32 b |
| Resistant Protein | n.d. | 16.03 ± 0.05 a | n.d. | 11.69 ± 0.03 b |
| Bond Phenolic | 7.80 ± 0.43 a | 31.18 ± 2.31 b | 4.99 ± 0.35 c | 34.10 ± 1.21 b |
* < LOD; n.d., nondeterminate; IDF, insoluble dietary fiber; SDF, soluble dietary fiber. **, mg GUAE/g fiber DW; ***, mg GAE/100 g fiber DW. Results are the means of three determinations ± standard deviation. Different letters in the same row are significantly different, as determined by ANOVA (p < 0.05).
Figure 2Total phenolics content (A), antioxidant capacity by ABTS (B), and ORAC (C) methods, gallic acid and p-coumaric acid concentration (D) throughout gastrointestinal tract of samples. SFCONV refers to solid fraction obtained after conventional extraction; SFOH refers to solid fraction obtained after ohmic heating extraction. Significant differences (p < 0.05) among extracts for each digested fraction are indicated by Greek letters.
Recovery index and bioaccessibility of total phenolic compounds, antioxidant activity, and individual phenolic compounds from SFCONV and SFOH samples throughout digestion.
| Recovery Index (%) | Bioaccessibility (%) | ||||||
|---|---|---|---|---|---|---|---|
| Bioactivities | Samples | Mouth | Stomach | Small Intestine | Colon | Basolateral | |
| Total Phenol | SFCONV | 101.42 ± 2.34 a | 124.11 ± 1.28 b | 121.99 ± 2.03 b | 90.78 ± 1.12 d | 9.22 ± 1.07 e | 7.03 ± 0.42 α |
| SFOH | 70.44 ± 1.56 a | 172.86 ± 2.34 b | 122.18 ± 1.24 c | 103.04 ± 1.28 d | 15.32 ± 1.25 e | 11.14 ± 0.76 β | |
| ABTS | SFCONV | 103.08 ± 2.23 a | 134.35 ± 1.78 b | 124.14 ± 2.02 c | 98.49 ± 2.45 a | 18.1 ± 1.96 d | 14.58 ± 0.13 α |
| SFOH | 81.45 ± 1.87 a | 175.71 ± 2.56 b | 108.26 ± 1.95 c | 92.51 ± 1.96 | 7.49 ± 0.06 d | 6.47 ± 0.15 β | |
| Orac | SFCONV | 109.34 ± 2.25 a | 121.65 ± 1.25 b | 119.60 ± 1.21 b | 90.49 ± 2.54 | 9.51 ± 0.07 d | 7.37 ± 0.31 α |
| SFOH | 89.19 ± 2.54 a | 160.36 ± 2.46 b | 108.26 ± 2.38 c | 87.50 ± 1.26 | 12.50 ± 1.01 d | 10.35 ± 0.12 β | |
| Phenolic compounds | |||||||
| gallic acid | SFCONV | 101.19 ± 1.87 a | 93.56 ± 1.17 b | 7.62 ± 0.97 c | n.d. | 93.56 ± 1.87 b | 92.46 ± 1.03 α |
| SFOH | 134.31 ± 1.12 | 8.45 ± 0.2 3 b | 29.76 ± 0.79 c | n.d. | 100.00 ± 2.05 d | 77.07 ± 1.44 β | |
| 4-hydroxybenzoic acid | SFCONV | 100.38 ± 1.56 a | 87.64 ± 1.68 b | 12.74 ± 0.26 c | n.d. | 87.64 ± 1.67 b | 87.31 ± 1.38 α |
| SFOH | 102.54 ± 1.69 a | 84.92 ± 1.78 b | 70.98 ± 1.45 c | 70.98 ± 0.13 c | 13.94 ± 1.36 | 16.42 ± 1.22 β | |
| SFCONV | 79.35 ± 2.56 a | 121.14 ± 1.27 b | 42.49 ± 0.08 c | 36.15 ± 0.89 d | 78.65 ± 1.23 a | 64.92 ± 1.12 α | |
| SFOH | 89.07 ± 1.98 a | 59.51 ± 1.25 b | 100.42 ± 2.76 c | 0.42 ± 0.03 d | 99.37 ± 3.01 c | 49.74 ± 1.12β | |
| rutin | SFCONV | 17.01 ± 0.54 a | n.d. | 68.83 ± 1.05 b | n.d. | 58.83 ± 2.16 c | 46.08 ± 1.56α |
| SFOH | 7.84 ± 0.05 a | n.d | n.d. | n.d. | 7.56 ± 0.34 a | 99.99 ± 0.66 β | |
Recovery index and bioaccessibility %; n.d., not determined. Results are the means of three determinations ± standard deviation. Different letters in the same row are significantly different (p < 0.05), the Greek alphabet symbol means significant differences between methods used in the same column (p < 0.05), as determined by ANOVA (p < 0.05).
Recovery index and bioaccessibility of carotenoids identified by UPLC-qTOF MS analysis from SFCONV and SFOH samples throughout digestion.
| Mouth | Stomach | Intestine | Colon | Basolateral | Bioaccessibility | |||
|---|---|---|---|---|---|---|---|---|
| Compounds | Mz | Samples | (%) | |||||
| n.i. | 525 | SFOH | 84.85 ± 2.31 a | 57.97 ± 1.3 b | 45.52 ± 1.56 c | 40.33 ± 1.87 c | 27.17 ± 1.84 d | 59.67 ± 1.83 β |
| SFCONV | 86.32 ± 2.05 a | 60.21 ± 1.31 b | 49.23 ± 1.55 c | 41.32 ± 1.98 d | 31.24 ± 2.13 e | 63.46 ± 1.76 α | ||
| n.i. | 527 | SFOH | 91.55 ± 1.95 a | 16.86 ± 0.25 b | 15.68 ± 0.99 b | 92.48 ± 2.06 a | 1.18 ± 1.23 c | 7.52 ± 0.74 α |
| SFCONV | 93.41 ± 1.28 a | 89.31 ± 2.45 b | 44.66 ± 2.87 c | 90.23 ± 2.77 a,b | 3.06 ± 0.22 d | 6.85 ± 0.32 β | ||
| phytofluene | 542 | SFOH | 72.25 ± 1.04 a | 36.46 ± 0.78 b | 29.14 ± 1.23 c | 69.82 ± 1.76 a | 8.79 ± 0.97 d | 30.18 ± 0.98 α |
| SFCONV | 26.40 ± 0.27 b | 11.53 ± 0.69 c | 37.08 ± 1.39 a | 35.54 ± 1.43 a | 3.21 ± 0.06 d | 8.66 ± 0.45 β | ||
| lycopene | 536 | SFOH | n.q | n.q | n.q | n.q | n.q | n.q |
| SF | n.q | n.q | n.q | n.q | n.q. | n.q | ||
| lutein | 569 | SFOH | 113.9 ± 2.76 a | 62.52 ± 1.43 b | 57.65 ± 1.43 c | 19.26 ± 1.25 e | 46.55 ± 1.54 d | 80.74 ± 1.32 α |
| SFCONV | 25.53 ± 0.34 c | 11.15 ± 0.98 d | 35.85 ± 1.41 a | 30.53 ± 1.23 b | 5.21 ± 0.09 e | 14.53 ± 0.57 β | ||
| n.i. | 633 | SFOH | 103.8 ± 2.54 a | 58.61 ± 1.77 b | 33.06 ± 1.04 c | 12.98 ± 0.12 d | 35.82 ± 2.31 c | 108.32 ± 2.25 α |
| SFCONV | n.d | n.d | n.d | n.d | n.d | n.q | ||
Results are the means of three determinations ± standard deviation; n.i., nonidentified; n.d., nondeterminate; n.q., nonquantified. Different letters in the same row are significantly different (p < 0.05), the Greek alphabet symbol means significant differences between methods used in the same column (p < 0.05), as determined by ANOVA (p < 0.05).
Volatile compounds analysis by GCMS.
| Compounds (Name) | 1,2-dimethylindole | 2,6-dimethylbenzaldehyde | Benzoic Acid | β-cyclocitral | 3,4-diethenyl-1,6-dimethyl- | Camphenol | Linalyl Acetate and Linalool | |
|---|---|---|---|---|---|---|---|---|
|
| 133 | 105 | 118 | 119 | 93 | 93 | 93 | |
| Molecular formula | C10H11N | C9H10O | C7H6O2 | C10H16O | C12H18 | C10H16O | C12H20O2/C10H18O | |
| MW | 145 | 134 | 122 | 152 | 162 | 152 | 196/154 | |
|
| CBF | 226.6 ± 13.4 | 0.4 ± 0.1 | 14.4 ± 4.5 | 3.3 ± 0.5 | 0.4 ± 0.1 | 14.1 ± 0.3 | 0.0 ± 0.0 |
| Mouth | 190.9 ± 5.4 | 2.7 ± 0.1 | 14.0 ± 0.9 | 2.0 ± 0.1 | 0.4 ± 0.0 | 9.2 ± 2.5 | 0.8 ± 0.3 | |
| Stomach | 189.0 ± 3.9 | 2.2 ± 0.4 | 4.1 ± 0.8 | 3.2 ± 0.4 | 0.9 ±0.1 | 10.4 ± 1.1 | 0.3 ± 0.1 | |
| Small Intestine | 113.1 ± 4.5 | 0.0 ± 0.0 | 1.6 ± 0.6 | 1.3 ±0.1 | 0.0 ± 0.0 | 0.4 ± 0.1 | 0.0 ± 0.0 | |
| Colon | 1.3 ± 0.1 | 0.0 ± 0.0 | 0.0 ± 0.0 | 0.0 ± 0.0 | 0.1 ± 0.0 | 1.10 ± 0.3 | 0.0 ± 0.0 | |
| Basolateral | 4.6 ±0.6 | 0.0 ± 0.0 | 20.8 ± 3.9 | 0.0 ± 0.0 | 0.0 ± 0.0 | 0.0 ± 0.0 | 0.0 ± 0.0 | |
|
| CBF | 232.1 ± 21.7 | 0.0 ±0.0 | 8.6 ± 1.4 | 2.8 ± 0.2 | 0.1 ± 0.0 | 2.8 ± 0.3 | 0.0 ± 0.0 |
| Mouth | 155.5 ± 12.43 | 1.5 ± 0.3 | 6.6 ± 1.8 | 2.6 ± 0.3 | 0.1 ± 0.0 | 3.1 ± 0.4 | 0.3 ± 0.1 | |
| Stomach | 208.5 ± 15.84 | 1.3 ± 0.2 | 4.6 ± 0.7 | 4.8 ± 0.5 | 0.1 ± 0.0 | 3.7 ± 0.7 | 0.2 ± 0.0 | |
| Small Intestine | 79.5 ± 7.49 | 0.0 ± 0.0 | 5.5 ± 0.8 | 1.3 ± 0.1 | 0.0 ± 0.0 | 0.5 ± 0.1 | 0.0 ± 0.0 | |
| Colon | 19.0 ± 4.61 | 0.0 ± 0.0 | 2.0 ±0.3 | 0.0 ± 0.0 | 0.3 ± 0.1 | 3.5 ± 0.7 | 0.0 ± 0.0 | |
| Basolateral | 17.3 ± 3.95 | 0.0 ± 0.0 | 39.4 ± 4.9 | 0.6 ± 0.1 | 0.0 ± 0.0 | 0.1 ± 0.0 | 0.0 ± 0.0 |
Results are given in µg per liter and are a result of the means of three determinations ± standard deviation.
Figure 3Metabolomic analysis, two-way ANOVA, OPLS-DA, and fold-change analysis.
Figure 4Cytotoxicity (A) and mutagenicity (B) of SFOH and SFCONV samples. In figure (B), represent without metabolization and with metabolization. Results are the means of three determinations ± standard deviation.
Figure 5Cumulative permeability of cells to SFOH and SFCONV samples.